Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer
Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer
Recruiting · NCT05620342 · Registry updated 2026-02-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung cancer, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Recruiting | Early phase 1 | 2026-02-05 | NCT05620342 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bellicum Pharmaceuticals | 12 |
| M.D. Anderson Cancer Center | 1145 |
| UNC Lineberger Comprehensive Cancer Center | 125 |
| United States Department of Defense | 319 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Lineberger Comprehensive Cancer Center | Chapel Hill | United States | 5 |